Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: May 15, 2008
Last updated: August 26, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2000
  Primary Completion Date: July 2000 (Final data collection date for primary outcome measure)